We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rafarma Pharmaceuticals Inc (PK) | USOTC:RAFA | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00495 | 7.12% | 0.07445 | 0.0661 | 0.0973 | 0.07445 | 0.07445 | 0.07445 | 10,000 | 22:00:02 |
Real Estate Contacts, Inc. (OTCQB: REAC) operates an online real estate advertising portal website and real estate video website that offers real estate professionals the opportunity to reach consumers interested in buying or selling property in their respective geographic area. The real estate sector appears to be making a come back after the 2008 crash. Get the full report including information on the REAC services and fundamentals here: http://bit.ly/OTCBBNEWRESEARCH
Rafarma Pharmaceuticals (OTC: RAFA) is a Russia-based multi-product pharmaceutical company focused on producing generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. The latest project that Rafarma has undergone includes initiatives to open a world-class manufacturing facility capable of producing all types and forms of medical drugs of diverse pharmacological groups. Get the full research report here: http://bit.ly/OTCBBNEWRESEARCH
EcoloCap Solutions Inc. (OTCQB: ECOS) has been quiet since November 6th, 2012 when they last released news. Here is an excerpt from that press release: Michael Siegel, President and CEO of EcoloCap, stated: "By the end of November we should finish testing of the 25% water blend M-Fuel on a 60kW CAT Genset as a follow-up to our preliminary test of a few weeks ago. We expect to show a 22% + reduction in diesel consumption and a minimum 85% reduction in particulate emissions, which surpasses the minimum expectations of our client for the electricity generation market. To estimate the size of this market, over 1 trillion (1,000,000,000,000) watts of electricity is generated each year by diesel or heavy fuel oil (HFO) worldwide. An NPU-60 produces 18,000 gallons per day, or enough fuel to power approximately 700,000 kilowatts of electricity. Many of the Diesel/HFO power installations will soon be required to reduce emissions and costs of operation. To put things into a realistic perspective, within two years ECOS expects to sell 18 NPU-60s to obtain 1% of the market, or 100,000,000 gallons per year. This represents recurring yearly gross revenue of $25,000,000 per year in additive sales. The use of M-Fuel will reduce or eliminate the need for pollution control methods and at the same time reduce costs substantially. Parallel testing starts on the delivering of M-Fuel samples to Great Britain and Ireland by mid-November." In the following report we have uncovered some positive information as recent as February 6th, 2013: http://bit.ly/OTCBBNEWRESEARCH
Be the First to know text "OTCBBAlerts" to 25827 for our latest picks
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have NOT been compensated for the mention of any of the companies in this press release.
Contact: Small-Cap Specialists LLC Email Contact
1 Year Rafarma Pharmaceuticals (PK) Chart |
1 Month Rafarma Pharmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions